Evidence map›Paper›PMID 38995543›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Analysis and Visualization of Protein Channels, Tunnels, and Pores with MOLEonline and ChannelsDB 2.0.

Anna Špačková, Václav Bazgier, Tomáš Raček, David Sehnal, Radka Svobodová, Karel Berka

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antibody-drug conjugate engineering: from design to efficacy and safety.Signal transduction and targeted therapy · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna ŠpačkováDepartment of Physical Chemistry, Faculty of Science, Palacký University Olomouc, Olomouc, Czech Republic.
Václav BazgierDepartment of Physical Chemistry, Faculty of Science, Palacký University Olomouc, Olomouc, Czech Republic.
Tomáš RačekCentral European Institute of Technology (CEITEC), Masaryk University Brno, Brno, Czech Republic.
David SehnalCentral European Institute of Technology (CEITEC), Masaryk University Brno, Brno, Czech Republic.
Radka SvobodováCentral European Institute of Technology (CEITEC), Masaryk University Brno, Brno, Czech Republic.
Karel BerkaDepartment of Physical Chemistry, Faculty of Science, Palacký University Olomouc, Olomouc, Czech Republic. karel.berka@upol.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Channels, tunnels, and pores serve as pathways for the transport of molecules and ions through protein structures, thus participating to their functions. MOLEonline ( https://mole.upol.cz ) is an interactive web-based tool with enhanced capabilities for detecting and characterizing channels, tunnels, and pores within protein structures. MOLEonline has two distinct calculation modes for analysis of channel and tunnels or transmembrane pores. This application gives researchers rich analytical insights into channel detection, structural characterization, and physicochemical properties. ChannelsDB 2.0 ( https://channelsdb2.biodata.ceitec.cz/ ) is a comprehensive database that offers information on the location, geometry, and physicochemical characteristics of tunnels and pores within macromolecular structures deposited in Protein Data Bank and AlphaFill databases. These tunnels are sourced from manual deposition from literature and automatic detection using software tools MOLE and CAVER. MOLEonline and ChannelsDB visualization is powered by the LiteMol Viewer and Mol* viewer, ensuring a user-friendly workspace. This chapter provides an overview of user applications and usage.

Indexed as

Databases, ProteinSoftwareComputational BiologyIon ChannelsModels, MolecularProtein ConformationProteinsUser-Computer InterfaceWeb BrowserIon ChannelsProteinsBiomacromoleculeChannelmmCIFPDBPhysicochemical propertiesPoreProteinResiduesTunnelVisualizationVoronoi

Identifiers

PMID38995543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.